A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis

被引：4

作者：

Yamazaki, Haruhiko ^{[1
]}

Iwasaki, Hiroyuki ^{[1
]}

Yamashita, Toshinari ^{[1
]}

Yoshida, Tatsuya ^{[1
]}

Suganuma, Nobuyasu ^{[1
]}

Yamanaka, Takashi ^{[1
]}

Masudo, Katsuhiko ^{[2
]}

Nakayama, Hirotaka ^{[3
]}

Kohagura, Kaori ^{[3
]}

Rino, Yasushi ^{[3
]}

Masuda, Munetaka ^{[3
]}

机构：

[1] Kanagawa Canc Ctr, Dept Breast & Endocrine Surg, Yokohama, Kanagawa, Japan

[2] Yokohama City Univ, Med Ctr, Dept Breast andThyroid Surg, Yokohama, Kanagawa, Japan

[3] Yokohama City Univ, Sch Med, Dept Surg, Yokohama, Kanagawa, Japan

来源：

CASE REPORTS IN ENDOCRINOLOGY | 2018年 / 2018卷

关键词：

D O I：

10.1155/2018/7875929

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 63-year-old man was diagnosed with multiple lung metastases from anaplastic thyroid cancer and received lenvatinib. Followup computed tomography on day 34 of lenvatinib treatment showed pneumothorax. The pneumothorax was temporarily improved with chest drainage. However, pleurodesis was performed to treat a relapse of the pneumothorax. Pneumothorax during chemotherapy for a malignant tumor is considered a relatively rare complication. This case is the first documentation that pneumothorax may develop during lenvatinib treatment. The possible development of pneumothorax should be considered when lenvatinib is used in patients with lung metastasis.

引用

页数：4

共 50 条

[21] Lenvatinib enhances the antitumor effects of paclitaxel in anaplastic thyroid cancer
Jing, Changxin
Gao, Zhifei
Wang, Rong
Yang, Zhao
Shi, Bingyin
Hou, Peng
AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (04): : 903 - 912
[22] Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer
Di Desidero, Teresa
Orlandi, Paola
Gentile, Daniela
Banchi, Marta
Ali, Greta
Kusmic, Claudia
Armanetti, Paolo
Cayme, Ginelle J.
Menichetti, Luca
Fontanini, Gabriella
Francia, Giulio
Bocci, Guido
PHARMACOLOGICAL RESEARCH, 2020, 158
[23] Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
Barbaro, Daniele
Forleo, Raffaella
Profilo, Maria Antonietta
Lapi, Paola
Giani, Carlotta
Torregrossa, Liborio
Macerola, Elisabetta
Materazzi, Gabriele
FRONTIERS IN ENDOCRINOLOGY, 2024, 15
[24] Successful Treatment by Surgery and Lenvatinib of a Patient with Adrenal Metastasis of Papillary Thyroid Cancer
Nakamura, Hajime
Takada, Kohichi
Murase, Kazuyuki
Sakamoto, Hiroki
Hayasaka, Naotaka
Ishikawa, Kazuma
Ikeda, Yuki
Yoshida, Makoto
Iyama, Satoshi
Kobayashi, Ko
Shindo, Tetsuya
Sugita, Shintaro
Miyanishi, Koji
Kobune, Masayoshi
Masumori, Naoya
Kato, Junji
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
[25] The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis
Hongen Guo
Hanqing Lin
BMC Surgery, 24
[26] The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis
Guo, Hongen
Lin, Hanqing
BMC SURGERY, 2024, 24 (01)
[27] Comprehensive Treatment of Anaplastic Thyroid Cancer: A Case Report
Liu, Jiaqi
Chu, Jun
ONCOTARGETS AND THERAPY, 2025, 18 : 325 - 333
[28] Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
Kishikawa, Masahiro
Inoue, Jun
Hamamoto, Hidetoshi
Kobayashi, Katsunori
Asakage, Takahiro
Inazawa, Johji
BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 26
[29] Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
Kim, Soo Young
Kim, Seok-Mo
Kim, Jun Won
Lee, Ik Jae
Jeon, Tae Joo
Chang, Hojin
Kim, Bup-Woo
Lee, Yong Sang
Chang, Hang-Seok
Park, Cheong Soo
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[30] Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
Lee, Jin-Seok
Lee, Jun Sung
Yun, Hyeok Jun
Chang, Hojin
Kim, Seok Mo
Lee, Yong Sang
Chang, Hang-Seok
Park, Cheong Soo
CANCERS, 2022, 14 (23)

← 1 2 3 4 5 →